BBS5 Monoklonaler Antikörper

BBS5 Monoklonal Antikörper für IF

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human, Maus

Anwendung

IF

Konjugation

CoraLite®594 Fluorescent Dye

CloneNo.

4G8E12

Kat-Nr. : CL594-66136

Synonyme

Bardet Biedl syndrome 5, BBS5

---

Galerie der Validierungsdaten

• 

  IF Staining of human kidney using CL594-66136

  Immunofluorescent analysis of (4% PFA) fixed human kidney tissue using CoraLite®594 BBS5 antibody (CL594-66136, Clone: 4G8E12 ) at dilution of 1:100.

• 

  IF Staining of human kidney using CL594-66136

  Immunofluorescent analysis of (4% PFA) fixed human kidney tissue using CoraLite®594 BBS5 antibody (CL594-66136, Clone: 4G8E12 ) at dilution of 1:100.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in IF: humanes Nierengewebe

Empfohlene Verdünnung

• Immunfluoreszenz (IF): IF : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

CL594-66136 bindet in IF BBS5 und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• Wirt / Isotyp: Maus / IgG1
• Klonalität: Monoklonal
• Typ: Antikörper
• Immunogen: BBS5 fusion protein Ag6844
• Vollständiger Name: Bardet-Biedl syndrome 5
• Berechnetes Molekulargewicht: 39 kDa
• GenBank-Zugangsnummer: BC044593
• Gene symbol: BBS5
• Gene ID (NCBI): 129880
• Konjugation: CoraLite®594 Fluorescent Dye
• Excitation/Emission maxima wavelengths: 588 nm / 604 nm
• Form: Liquid
• Reinigungsmethode: Protein-G-Reinigung
• Lagerungspuffer: BS mit 50% Glyzerin, 0,05% Proclin300, 0,5% BSA, pH 7,3.
• Lagerungsbedingungen: Bei -20°C lagern. Vor Licht schützen. Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

BBS5 encodes a protein that has been directly linked to Bardet-Biedl syndrome. Bardet-Biedl syndrome (BBS) is an autosomal recessive condition characterised by rod-cone dystrophy, postaxial polydactyly, central obesity, mental retardation, hypogonadism, and renal dysfunction. Other associated clinical findings in BBS patients include diabetes, hypertension and congenital heart defects. BBS expression varies both within and between families and diagnosis is often difficult. Experimentation in non-human eukaryotes suggests that BBS5 is expressed in ciliated cells and that it is required for the formation of cilia. Alternate transcriptional splice variants have been observed but have not been fully characterized.